000			01447 a2200421 4500
005			20250513081325.0
264		0	_c19930506
008			199305s 0 0 eng d
022			_a0041-1345
040			_aNLM _beng _cNLM
100	1		_aNorman, D J
245	0	0	_aCytokine-release syndrome: differences between high and low doses of OKT3. _h[electronic resource]
260			_bTransplantation proceedings _cApr 1993
300			_a35-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAntilymphocyte Serum _xtherapeutic use
650	0	4	_aAzathioprine _xtherapeutic use
650	0	4	_aCyclosporine _xtherapeutic use
650	0	4	_aCytokines _xphysiology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGraft Rejection _ximmunology
650	0	4	_aHistocompatibility Testing
650	0	4	_aHumans
650	0	4	_aImmunosuppression Therapy _xmethods
650	0	4	_aKidney Transplantation _ximmunology
650	0	4	_aMale
650	0	4	_aMethylprednisolone _xtherapeutic use
650	0	4	_aMuromonab-CD3 _xadverse effects
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aSyndrome
700	1		_aKimball, J A
700	1		_aBarry, J M
773	0		_tTransplantation proceedings _gvol. 25 _gno. 2 Suppl 1 _gp. 35-8
999			_c8464690 _d8464690